JP2012198248A5 - - Google Patents

Download PDF

Info

Publication number
JP2012198248A5
JP2012198248A5 JP2012165085A JP2012165085A JP2012198248A5 JP 2012198248 A5 JP2012198248 A5 JP 2012198248A5 JP 2012165085 A JP2012165085 A JP 2012165085A JP 2012165085 A JP2012165085 A JP 2012165085A JP 2012198248 A5 JP2012198248 A5 JP 2012198248A5
Authority
JP
Japan
Prior art keywords
flc
assay kit
sample
amount
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012165085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012198248A (ja
Filing date
Publication date
Priority claimed from GBGB0914535.0A external-priority patent/GB0914535D0/en
Application filed filed Critical
Publication of JP2012198248A publication Critical patent/JP2012198248A/ja
Publication of JP2012198248A5 publication Critical patent/JP2012198248A5/ja
Pending legal-status Critical Current

Links

JP2012165085A 2009-08-19 2012-07-25 生存率予測アッセイ Pending JP2012198248A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0914535.0 2009-08-19
GBGB0914535.0A GB0914535D0 (en) 2009-08-19 2009-08-19 Prognosis assay
GB1001079.1 2010-01-22
GBGB1001079.1A GB201001079D0 (en) 2009-08-19 2010-01-22 Prognostic assay

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012525213A Division JP2013502569A (ja) 2009-08-19 2010-08-19 生存率予測アッセイ

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015011976A Division JP2015092190A (ja) 2009-08-19 2015-01-26 生存率予測アッセイ

Publications (2)

Publication Number Publication Date
JP2012198248A JP2012198248A (ja) 2012-10-18
JP2012198248A5 true JP2012198248A5 (enExample) 2014-04-24

Family

ID=41171642

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012525213A Pending JP2013502569A (ja) 2009-08-19 2010-08-19 生存率予測アッセイ
JP2012165085A Pending JP2012198248A (ja) 2009-08-19 2012-07-25 生存率予測アッセイ
JP2015011976A Pending JP2015092190A (ja) 2009-08-19 2015-01-26 生存率予測アッセイ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012525213A Pending JP2013502569A (ja) 2009-08-19 2010-08-19 生存率予測アッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015011976A Pending JP2015092190A (ja) 2009-08-19 2015-01-26 生存率予測アッセイ

Country Status (11)

Country Link
US (1) US20120220052A1 (enExample)
EP (2) EP2799879A3 (enExample)
JP (3) JP2013502569A (enExample)
CN (1) CN102639999B (enExample)
DE (1) DE202010018327U1 (enExample)
DK (1) DK2467724T3 (enExample)
ES (1) ES2517922T3 (enExample)
GB (3) GB0914535D0 (enExample)
PL (1) PL2467724T3 (enExample)
PT (1) PT2467724E (enExample)
WO (1) WO2011021041A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB2478520A (en) * 2010-03-02 2011-09-14 Binding Site Group Ltd Kidney prognostic assay
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201202964D0 (en) 2012-02-21 2012-04-04 Binding Site Group The Ltd Correction method
GB201203938D0 (en) 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
CN102636653A (zh) * 2012-04-19 2012-08-15 上海蓝怡科技有限公司 复合胶乳粒子包被胱抑素c检测试剂盒
GB201212900D0 (en) * 2012-07-20 2012-09-05 Binding Site Group The Ltd Triage scoring system
GB201218137D0 (en) * 2012-10-10 2012-11-21 Binding Site Group The Ltd Chronic kidney disease assay
CN103175964B (zh) * 2013-02-21 2015-08-26 武汉华美生物工程有限公司 神经元特异性烯醇化酶含量检测试剂盒及其制备方法
US10267806B2 (en) 2014-04-04 2019-04-23 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201603359D0 (en) 2016-02-26 2016-04-13 Binding Site Group The Ltd Improved assay
GB201708262D0 (en) * 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044219A1 (en) * 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
IT1216698B (it) 1988-04-01 1990-03-08 New Scient Co Spa Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente.
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005103717A1 (en) * 2004-04-21 2005-11-03 Fornix Biosciences N.V. Measuring free light chains of immunoglobulin
DE102004038726B4 (de) * 2004-07-15 2006-05-18 Levin, Felix, Dr. Testsystem und Verfahren zur schnellen Bestimmung von Bence Jones Protein in biologischen Flüssigkeiten
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
EP2267449B1 (en) * 2005-04-12 2014-01-08 Akira Matsumori Biomarker for diagnosing heart failure and the use thereof
GB0608446D0 (en) * 2006-04-27 2006-06-07 Binding Site The Ltd Assay
GB0819720D0 (en) * 2008-10-28 2008-12-03 Univ Birmingham Methods and products
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay

Similar Documents

Publication Publication Date Title
JP2012198248A5 (enExample)
JP2013502569A5 (enExample)
Ishikura et al. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study
Blom et al. Rapid progression from mild cognitive impairment to Alzheimer’s disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE ε 4/ε 4 genotype
AU2008201621B8 (en) A method for predicting the presence of haemostatic dysfunction in a patient sample
Bae et al. Prealbumin levels as a useful marker for predicting infectious complications after gastric surgery
CN102639999B (zh) 存活预后分析
US20140350129A1 (en) Diagnostic assay to predict cardiovascular risk
Steubl et al. C-terminal agrin fragment-a new fast biomarker for kidney function in renal transplant recipients
CA3052349A1 (en) Proadm as marker indicating an adverse event
AU6617900A (en) A method for predicting the presence of haemostatic dysfunction in a patient sample
JP2013521490A (ja) 腎臓予後予測アッセイ
RU2015116674A (ru) Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции
RU2017115663A (ru) Способы и системы для отличия синдрома раздраженного кишечника от воспалительного заболевания кишечника и глютеновой болезни
US12000845B2 (en) Method for discharging a patient from an intensive care unit
Reichel Acute kidney injury: quoi de neuf?
AU2001266795B2 (en) A method for detecting a lipoprotein-acute phase protein complex
Buser et al. Evaluation of C‐reactive protein and its kinetics as a prognostic indicator in canine leptospirosis
Ebik et al. What is the incidence of celiac disease in patients with microscopic colitis? Why are these two diseases related?
JP5818818B2 (ja) 感染症予後診断アッセイ
JP6158825B2 (ja) テネイシンcおよび関節リウマチにおけるその使用
Renda et al. The glomerular filtration rate and proteinuria in obese children
Popiolek et al. Changes of serum cell adhesion molecules as potential markers of inflammation severity, metabolic status and mortality in patients infected with COVID-19.
Mollnes et al. Complement analysis in clinic and research
JP2015503106A5 (enExample)